Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -424.89% is 601% below its 5-year average of -60.64%, near the low end of its 5-year range (-424.89%–9.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 90.14% below its 12-month average of -223.46%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -424.89%.
RETURN ON EQUITY (ROE)
-424.89%
RETURN ON EQUITY (ROE) AVG TTM
-223.46%
RETURN ON EQUITY (ROE) AVG 3Y
-100.81%
RETURN ON EQUITY (ROE) AVG 5Y
-60.64%
RETURN ON EQUITY (ROE) AVG 10Y
-120.47%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-90.14%
CURRENT VS 3Y AVG
-321.46%
CURRENT VS 5Y AVG
-600.70%
CURRENT VS 10Y AVG
-252.69%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
-1080.09%
vs the sector median at left
CollPlant Biotechnologies Ltd.
Market Cap
$4.42M
Return on Equity (ROE)
-424.89%
TTM Avg
-223.46%
3Y Avg
-100.81%
5Y Avg
-60.64%
Market Cap
$4.41M
Return on Equity (ROE)
-383.03%
TTM Avg
-1602.50%
3Y Avg
-1094.59%
5Y Avg
-783.90%
Market Cap
$4.46M
Return on Equity (ROE)
-239.95%
TTM Avg
-454.28%
3Y Avg
-297.70%
5Y Avg
-194.53%
Market Cap
$4.32M
Return on Equity (ROE)
-184.04%
TTM Avg
9542.92%
3Y Avg
4740.03%
5Y Avg
3155.09%
Market Cap
$4.18M
Return on Equity (ROE)
N/A
TTM Avg
-201.28%
3Y Avg
-1309.54%
5Y Avg
-838.52%
Market Cap
$4.79M
Return on Equity (ROE)
-30.74%
TTM Avg
235.96%
3Y Avg
-836.91%
5Y Avg
-570.34%
Market Cap
$4.85M
Return on Equity (ROE)
-385.27%
TTM Avg
175.03%
3Y Avg
3.40%
5Y Avg
-11.76%
Market Cap
$3.94M
Return on Equity (ROE)
-437.15%
TTM Avg
-328.44%
3Y Avg
-188.67%
5Y Avg
-533.64%
Market Cap
$4.96M
Return on Equity (ROE)
-248.66%
TTM Avg
-110.63%
3Y Avg
-33.84%
5Y Avg
-33.84%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CollPlant Biotechnologies Ltd. (CLGN) | $4.42M | -424.89% | -223.46% | -100.81% | -60.64% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -383.03% | -1602.50% | -1094.59% | -783.90% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | -239.95% | -454.28% | -297.70% | -194.53% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -184.04% | 9542.92% | 4740.03% | 3155.09% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | -201.28% | -1309.54% | -838.52% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | -30.74% | 235.96% | -836.91% | -570.34% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -385.27% | 175.03% | 3.40% | -11.76% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.94M | -437.15% | -328.44% | -188.67% | -533.64% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | -248.66% | -110.63% | -33.84% | -33.84% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | -42.05% | -32.76% | -25.11% | -45.26% |
ROE
-424.9%
ROA
-173.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -424.89% |
| 2026-03-31 | -268.81% |
| 2025-12-31 | -188.93% |
| 2025-09-30 | -130.68% |
| 2025-06-30 | -103.98% |
| 2025-03-31 | -111.85% |
| 2024-12-31 | -123.35% |
| 2024-09-30 | -102.97% |
| 2024-06-30 | -84.28% |
| 2024-03-31 | -30.67% |
| 2023-12-31 | -24.77% |
| 2023-09-30 | -20.78% |
| 2023-06-30 | -18.68% |
| 2023-03-31 | -56.14% |
| 2022-12-31 | -52.43% |
| 2022-09-30 | -45.51% |
| 2022-06-30 | -37.95% |
| 2022-03-31 | -31.82% |
| 2021-12-31 | 0.53% |
| 2021-09-30 | 2.28% |
| 2021-06-30 | 9.88% |
| 2021-03-31 | 11.75% |
| 2020-12-31 | -128.97% |
| 2020-09-30 | -105.66% |
| 2020-06-30 | -192.90% |
| 2020-03-31 | -143.36% |
| 2019-12-31 | -265.61% |
| 2019-06-30 | -196.94% |
| 2019-03-31 | -126.08% |
| 2018-12-31 | -83.29% |
| 2018-09-30 | -179.16% |
| 2018-06-30 | -182.05% |
| 2018-03-31 | -130.61% |
| 2017-12-31 | -222.30% |
| 2017-09-30 | -999.67% |
| 2017-06-30 | -415.67% |
| 2017-03-31 | -330.79% |
| 2016-12-31 | -541.32% |
| 2016-09-30 | -208.99% |
| 2016-06-30 | -135.80% |
| 2016-03-31 | -177.23% |
| 2015-12-31 | -161.32% |
| 2015-09-30 | -102.62% |
| 2015-06-30 | -163.13% |
| 2014-12-31 | -97.97% |
| 2014-09-30 | -83.96% |
| 2014-06-30 | -20.95% |
| 2014-03-31 | -64.90% |
| 2013-12-31 | -59.11% |
| 2013-09-30 | -371.57% |
| 2013-06-30 | -229.62% |
